60031-47-2

Usage

Uses

Used in Pharmaceutical Industry:
1-(1-methyl-1H-pyrazol-3-yl)ethanol is used as a building block for the synthesis of various pharmaceuticals and bioactive molecules, due to its versatile chemical structure and beneficial properties.
Used in Cosmetics and Personal Care Industry:
1-(1-methyl-1H-pyrazol-3-yl)ethanol is used as an ingredient in the formulation of cosmetics and personal care products for its ability to protect and repair skin damage, making it a promising candidate for products aimed at skin health and rejuvenation.
Overall, MPE holds promise as a versatile and beneficial compound with a range of potential applications in medicinal and cosmetic fields, leveraging its antioxidant and anti-inflammatory properties to address various health and beauty concerns.

Upstream product

• 151049-87-5 3-bromo-1-methyl-1H-pyrazole 
• 75-07-0 acetaldehyde 
• 75-16-1 methylmagnesium bromide 
• 27258-32-8 1-methyl-1H-pyrazole-3-carbaldehyde 

Relevant academic research and scientific papers

Pyrazolopyridine compound and use thereof

The present invention relates to a pyrazolopyridine compound and use thereof, and further relates to a pharmaceutical composition comprising the pyrazolopyridine compound. The pyrazolopyridine compound or the pharmaceutical composition can be used as a so

4,5,6,7-TETRAHYDRO-1 H-PYRAZOLO[4,3-C]PYRIDIN-3-AMINE COMPOUNDS AS CBP AND/OR EP300 INHIBITORS

The present invention relates to compounds of formula (I) or formula (II): and to salts thereof, wherein R1-R4 of formula (I) and R1-R3 of formula (II) have any of the values defined herein, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) of formula (II) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders.

Synthesis of 3-Substituted-1-methylpyrazoles

Reaction of 3-bromo-1-methylpyrazole 1 with t-butyllithium at -100 deg C followed by quenching of the lithiopyrazole intermediate allows regiospecific introduction of substituents into the 3-position of the 1-methylpyrazole ring.